Search - tctmd.com

Displaying 1 - 20 of 171

Sort: Relevancy | Date

INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen Over Time

News Conference News TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Michael O'Riordan

October 29, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Conference News CX Symposium 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

L.A. McKeown

April 24, 2025

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News ESC 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Michael O'Riordan

September 09, 2024

News Daily News

FDA Medical Devices Chief Jeff Shuren Announces Retirement

L.A. McKeown

July 24, 2024

News Conference News ACC 2024

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

L.A. McKeown

April 08, 2024

News Conference News ISET 2024

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

Caitlin E. Cox

January 31, 2024

News Conference News EAS 2023

Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1

Michael O'Riordan

May 25, 2023

News Conference News EuroPCR 2023

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

Michael O'Riordan

May 18, 2023

News Industry News

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

September 13, 2022

News Features

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Shelley Wood

March 14, 2022

News Daily News

Bioresorbable PFO/ASD Closure Device Shows Promise, but More Research Needed

Yael L. Maxwell

November 02, 2021

News Conference News TCT 2021

Good Long-term Results With FANTOM BVS, but More Data Needed

Michael O'Riordan

October 21, 2021

News Daily News

DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

Caitlin E. Cox

September 15, 2021

News Conference News EuroPCR 2021

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

Michael O'Riordan

May 19, 2021

News Daily News CRT 2021

COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold

Michael O'Riordan

March 17, 2021

News Conference News VIVA 2020

BVS Reboot? Signs of Durability to 2 Years in Critical Limb-Threatening Ischemia

L.A. McKeown

November 11, 2020

News Conference News EuroPCR 2020

DynamX Bioadaptor Provides Promising Preliminary Results for De Novo Coronary Lesions

Todd Neale

June 30, 2020

News Conference News CRT 2020

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

Michael O'Riordan

February 28, 2020

Advertisement

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

FDA Medical Devices Chief Jeff Shuren Announces Retirement

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Bioresorbable PFO/ASD Closure Device Shows Promise, but More Research Needed

Good Long-term Results With FANTOM BVS, but More Data Needed

DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold

BVS Reboot? Signs of Durability to 2 Years in Critical Limb-Threatening Ischemia

DynamX Bioadaptor Provides Promising Preliminary Results for De Novo Coronary Lesions

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content